In ccRCC this gender bias in gene mutation frequency is noteworthy because 30–40% of male ccRCCs demonstrate loss of the Y chromosome, which deletes amongst others the KDM5D gene17,18. Here, KDM5D is linked to nonpapillary renal cell carcinoma.